The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J. Neurol. Neurosurg. Psychiatry 57, 416–418 (1994).

Article  Google Scholar 

Brooks, B. R., Miller, R. G., Swash, M. & Munsat, T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, 293–299 (2000).

Article  CAS  Google Scholar 

de Carvalho, M. et al. The Awaji criteria for diagnosis of ALS. Muscle Nerve 44, 456–457 (2011).

Article  PubMed  Google Scholar 

Ludolph, A. et al. A revision of the El Escorial criteria — 2015. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 291–292 (2015).

Article  PubMed  Google Scholar 

Neary, D. & Snowden, J. Frontal lobe dementia, motor neuron disease, and clinical and neuropathological criteria. J. Neurol. Neurosurg. Psychiatry 84, 713–714 (2013).

Article  PubMed  Google Scholar 

Neary, D. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546–1554 (1998).

Article  CAS  PubMed  Google Scholar 

Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Shefner, J. M. et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 131, 1975–1978 (2020).

Article  PubMed  Google Scholar 

Strong, M. J. et al. Amyotrophic lateral sclerosis — frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 153–174 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Benatar, M. et al. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity. Brain 145, 3500–3508 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Benatar, M., Wuu, J., Andersen, P. M., Lombardi, V. & Malaspina, A. Neurofilament light: a candidate biomarker of pre-symptomatic ALS and phenoconversion. Ann. Neurol. 84, 130–139 (2018).

Article  CAS  PubMed  Google Scholar 

Bjornevik, K. et al. Prediagnostic neurofilament light chain levels in amyotrophic lateral sclerosis. Neurology 97, e1466–e1474 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Smith, E. N. et al. Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank. Amyotroph. Lateral Scler. Frontotemporal Degener. 25, 170–176 (2024).

Article  CAS  PubMed  Google Scholar 

Benatar, M. et al. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 145, 27–44 (2022).

Article  PubMed  Google Scholar 

Boeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y. & Rohrer, J. D. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 21, 258–272 (2022).

Article  CAS  PubMed  Google Scholar 

Benussi, A. et al. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimers Dement. 18, 1408–1423 (2022).

Article  PubMed  Google Scholar 

Mitsumoto, H., Kasarskis, E. J. & Simmons, Z. Hastening the diagnosis of amyotrophic lateral sclerosis. Neurology 99, 60–68 (2022).

Article  CAS  PubMed  Google Scholar 

Benatar, M. & Wuu, J. Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology 79, 1732–1739 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Estevez-Fraga, C. et al. Expanding the spectrum of movement disorders associated with C9orf72 hexanucleotide expansions. Neurol. Genet. 7, e575 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Daube, J. R. Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve 23, 1488–1502 (2000).

Article  CAS  PubMed  Google Scholar 

Swash, M. Shortening the time to diagnosis in ALS: the role of electrodiagnostic studies. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, S67–S72 (2000).

Article  Google Scholar 

Johnsen, B. et al. Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity. Clin. Neurophysiol. 130, 307–314 (2019).

Article  CAS  PubMed  Google Scholar 

Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183–194 (2004).

Article  CAS  PubMed  Google Scholar 

Benatar, M., Turner, M. R. & Wuu, J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 303–309 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Brooks, B. R. The role of axonal transport in neurodegenerative disease spread: a meta-analysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can. J. Neurological Sci. 18, 435–438 (1991).

Article  CAS  Google Scholar 

Grossman, M. et al. Frontotemporal lobar degeneration. Nat. Rev. Dis. Prim. 9, 40 (2023).

Article  PubMed  Google Scholar 

Leroy, M. et al. Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network. Alzheimers Res. Ther. 13, 19 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Boeve, B. et al. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology. Alzheimers Dement. 16, 22–36 (2020).

Article  PubMed  Google Scholar 

Olney, N. T. et al. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement. 16, 49–59 (2020).

Article  PubMed  Google Scholar 

Barker, M. S. et al. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 145, 1079–1097 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Brooks, B. R. El Escorial World Federation of Neurology Criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurological Sci. 124, 96–107 (1994).

Article  Google Scholar 

Taylor, L. J. et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J. Neurol. Neurosurg. Psychiatry 84, 494–498 (2013).

Article  PubMed  Google Scholar 

Abrahams, S. Executive dysfunction in ALS is not the whole story. J. Neurol. Neurosurg. Psychiatry 84, 474–475 (2013).

Article  PubMed  Google Scholar 

Saxon, J. A. et al. Semantic dementia, progressive non-fluent aphasia and their association with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 88, 711–712 (2017).

Article  PubMed  Google Scholar 

Kendler, K. S. The phenomenology of major depression and the representativeness and nature of DSM criteria. Am. J. Psychiatry 173, 771–780 (2016).

Article  PubMed  Google Scholar 

Tipton, P. W. et al. Differences in motor features of C9orf72, MAPT, or GRN variant carriers with familial frontotemporal lobar degeneration. Neurology 99, e1154–e1167 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siuda, J., Fujioka, S. & Wszolek, Z. K. Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat. Disord. 20, 957–964 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Rowe, J. B., Holland, N. & Rittman, T. Progressive supranuclear palsy: diagnosis and management. Pract. Neurol. 21, 376–383 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Espay, A. J. & Litvan, I. Parkinsonism and frontotemporal dementia: the clinical overlap. J. Mol. Neurosci. 45, 343–349 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Pablo-Fernandez, E. et al. A clinicopathologic study of movement disorders in frontotemporal lobar degeneration. Mov. Disord. 36, 632–641 (2021).

Article  PubMed  Google Scholar 

Gasca-Salas, C. et al. Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis. PLoS ONE 11, e0153852 (2016).

留言 (0)

沒有登入
gif